Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Vericel to Participate in the Canaccord Genuity MedTech, Diagnostics, and Digital Health & Service Forum and the Stephens Annual Investment Conference
-
Vericel to Participate in the Canaccord Genuity MedTech, Diagnostics, and Digital Health & Service Forum and the Stephens Annual Investment Conference
-
UPDATE: Canaccord Genuity Upgrades Repro Med Systems (KRMD) to Buy
-
UPDATE: Canaccord Genuity Downgrades PARTS iD (ID) to Hold
-
InterVenn Biosciences to Participate in Canaccord Genuity’s MedTech, Diagnostics and Digital Health & Services Forum
-
Lucid Diagnostics to Participate in Canaccord Genuity’s MedTech, Diagnostics and Digital Health & Services Forum
-
QuoteMedia Announces 15% Revenue Growth for Q3 2022
-
MIMEDX to Present at Upcoming Investor Conferences
-
Triple Flag and Maverix to Combine: Building the Next Senior Precious Metals Streaming and Royalty Company
-
TRIPLE FLAG AND MAVERIX TO COMBINE: BUILDING THE NEXT SENIOR PRECIOUS METALS STREAMING AND ROYALTY COMPANY
-
Cardiovascular Systems, Inc. to Participate in Two November Healthcare Conferences
-
T2 Biosystems to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
-
Atalaya Mining PLC Announces PDMR Share Dealing
-
DocGo Announces Upcoming Participation in Four Investor Conferences
-
UPDATE: Canaccord Genuity Downgrades Unisys (UIS) to Hold
-
UPDATE: Canaccord Genuity Downgrades Bioventus Inc (BVS) to Hold
-
IsoPlexis to Participate in Upcoming Investor Conferences
-
IsoPlexis to Participate in Upcoming Investor Conferences
-
Today’s important price target changes
-
Today's most important initiations
-
Artivion to Participate in Upcoming Investor Conferences
-
Exagen Inc. to Participate in Fourth Quarter Investor Conferences
-
Exagen Inc. to Participate in Fourth Quarter Investor Conferences
-
Parse Biosciences to Participate in Canaccord Genuity Investor Conference
-
Inventus Announces New Director
-
QuoteMedia Q3 2022 Financial Results and Investors’ Conference Call November 10, 2022
-
Vizsla Silver (VZLA) Announces Upsize to Previously Announced Bought Deal Financing to $30 Million
-
Vizsla Silver Announces Upsize to Previously Announced Bought Deal Financing to $30 Million
-
Li-FT Appoints New Chief Executive Officer and President
-
Yamana Gold (AUY) Enters Into Arrangement Agreement With Agnico (AEM) and Pan American (PAAS) and Announces Change of Recommendation
-
Investors dump Lyft on rising fears of Uber taking market share
-
Yamana Enters Into Arrangement Agreement With Agnico and Pan American and Announces Change of Recommendation
-
Yamana Enters Into Arrangement Agreement With Agnico and Pan American and Announces Change of Recommendation
-
UPDATE: Canaccord Genuity Initiaties Tenaya Therapeutics Inc (TNYA) at Buy (correction)
-
Vizsla Silver (VZLA) Prices 13.8M Share Bought Deal Offering at $1.45/sh
-
Vizsla Silver Announces $20 Million Bought Deal Financing
-
AppHarvest announces Q3 2022 results and makes significant progress in bringing four-farm network consisting of 165 acres online by end of year
-
AppHarvest announces Q3 2022 results and makes significant progress in bringing four-farm network consisting of 165 acres online by end of year
-
CSE Bulletin: New Listing - Heartfield Mining Corp. (HMC)
-
Canaccord Genuity Downgrades Blue Apron (APRN) to Hold
-
Dante Genomics to present at The Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
-
Dante Genomics to present at The Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
-
Blocklisting Application and Change of Auditor
-
Biotalys announces participation at investor and industry events for the remainder of 2022
-
Form 8.3 - [National World plc - Opening Declaration - 03 11 2022] - CGAML (formerly HHL)
-
Form 8.3 - [Reach plc - Opening Declaration - 03 11 2022] - CGAML (formerly HHL)
-
Pulmonx to Participate at Upcoming Investor Conferences
-
Pulmonx to Participate at Upcoming Investor Conferences
-
Akero Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
-
Akero Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update

